Calumet’s powerful specialty-refining cash engine and capital-efficient SAF scale-up create substantial upside, but the USD 480.2 million RIN liability keeps leverage-driven downside acute.
Overview
Calumet, Inc. (NASDAQ: CLMT) converted from an MLP to a C-Corporation in July 2024 and operates three segments: Specialty Products and Solutions, Performance Brands, and Montana/Renewables. It processes domestic crude and waste agricultural feedstocks into more than 1,900 specialty products and fuels for approximately 2,400 customers. **Q2 2026 demonstrated strong underlying cash generation:** sales rose 40.8% year over year to USD 1,445.1 million, while Adjusted EBITDA with Tax Attributes increased 129% to USD 175.2 million and free cash flow reached USD 99.35 million. The reported USD 95.9 million GAAP loss was distorted by a USD 163.6 million non-cash RIN expense and derivative mark-to-market adjustments. The investment case combines a defensive specialty-refining cash engine with high-growth SAF optionality. Management expects Restricted Group leverage below 3.0x in Q3 2026 after debt repayments. However, total debt was USD 2,258.7 million, equity was negative USD 1,137.1 million, and the USD 480.2 million RIN obligation creates material downside. Analysts remain cautious: consensus is Hold with a USD 42.75 target, although Goldman Sachs raised its target to USD 45.00.